Skip to main content
CKD Bio Corp. logo

CKD Bio Corp. — Investor Relations & Filings

Ticker · 063160 ISIN · KR7063160006 LEI · 988400RFJ8DLB1NTOE10 KO Manufacturing
Open in API
Filings indexed 146 across all filing types
Latest filing 2023-02-16 AGM Information
Country KR South Korea
Listing KO 063160

About CKD Bio Corp.

https://www.ckdbio.com/en/home

CKD Bio Corp. is a pharmaceutical company specializing in fermentation and chemical synthesis technologies. The company develops and manufactures a range of products, including Active Pharmaceutical Ingredients (APIs), intermediates, and probiotics. Its API portfolio features fermentation-based products such as antibiotics, ß-lactamase inhibitors, and immunosuppressants. Leveraging extensive experience in fermentation, CKD Bio also produces next-generation probiotics using patented technology. Additionally, the company provides Contract Manufacturing (CMO) and Contract Research (CRO) services for APIs and intermediates, utilizing its cGMP-certified production facilities.

Recent filings

Filing Released Lang Actions
주주총회소집결의
AGM Information Classification · 98% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) for Chong Kun Dang Bio. It outlines the date, location, and agenda items (financial statements, board appointments, and remuneration limits). This type of document is a standard proxy solicitation material provided to shareholders to inform them of upcoming meeting details and voting items, which falls under the Proxy Solicitation & Information Statement category.
2023-02-16 Korean
매출액또는손익구조30%(대규모법인은15%)이상변경
Earnings Release Classification · 100% confidence The document is a regulatory filing from a Korean company (Chong Kun Dang Bio) announcing a significant change (over 15%) in its financial results (revenue/profit/loss). This is a standard 'Earnings Release' (ER) filing in the Korean market, where companies provide preliminary financial data before the final audited report is published. It contains key financial highlights, reasons for the change, and a disclaimer that the data is subject to audit, which is characteristic of an Earnings Release. FY 2022
2023-01-30 Korean
투자판단관련주요경영사항
Regulatory Filings Classification · 100% confidence The document is a regulatory filing from Chong Kun Dang Bio regarding a 'Major Management Matter' (투자판단 관련 주요경영사항), specifically the submission of an Investigational New Drug (IND) application for a Phase 3 clinical trial of a botulinum toxin product. This type of disclosure regarding clinical trial progress and regulatory filings in South Korea is categorized under 'Regulatory Filings' (RNS) as it does not fit into specific categories like M&A, dividends, or financial reports.
2022-11-22 Korean
분기보고서 (2022.09)
Interim / Quarterly Report Classification · 100% confidence The document is a '분기보고서' (Quarterly Report) for the company '종근당바이오' (CKD Bio Corp.) covering the period from 2022.01.01 to 2022.09.30. It contains detailed financial statements, management discussion and analysis, and corporate governance information, which aligns with the definition of an Interim/Quarterly Report (IR). 9M 2022
2022-11-14 Korean
영업(잠정)실적(공정공시)
Earnings Release Classification · 100% confidence The document is a 'Provisional Earnings Release' (영업(잠정)실적) for Chong Kun Dang Bio for the third quarter of 2022. It provides key financial highlights such as revenue, operating profit, and net income in a summary table format. This fits the definition of an Earnings Release (ER), which is an initial announcement of quarterly financial results. Q3 2022
2022-10-28 Korean
반기보고서 (2022.06)
Interim / Quarterly Report Classification · 100% confidence The document is a '반기보고서' (Semi-Annual Report) for the company '종근당바이오' covering the period from 2022.01.01 to 2022.06.30. It contains comprehensive financial statements, management discussion, and operational details, which aligns with the definition of an Interim/Quarterly Report (IR). H1 2022
2022-08-16 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.